Formosa Laboratories, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Formosa Laboratories, Inc. - overview
Established
1995
Location
Taoyuan District, -, Taiwan - China
Primary Industry
Pharmaceuticals
About
Founded in 1995 and based in Taoyuan, Taiwan, Formosa Laboratories, Inc. is a biopharmaceutical company that develops antibodies that contain vitamin D for skin protection.
Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Aesthetic Medicine, Pharmaceutical Research & Development
Website
www.formosalab.com
Verticals
HealthTech
Total Amount Raised
Subscriber access only
Formosa Laboratories, Inc. - financials
| Fiscal Year Ended | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 2,625,647,000 | 2,524,282,000 | 2,473,633,000 | 2,496,224,000 | 2,596,722,000 | 3,189,380,000 | 2,539,353,000 | 2,687,731,000 | 2,759,591,000 | 3,075,457,000 | 3,142,406,000 | - | - | - |
| % Revenue Growth (YoY) | - | (3.9%) | (2.0%) | 0.9% | 4.0% | 22.8% | (20.4%) | 5.8% | 2.7% | 11.4% | 2.2% | - | - | - |
| EBITDA (USD) | 363,618,000 | 170,562,000 | 75,552,000 | 467,449,000 | 556,698,000 | 928,520,000 | 661,310,000 | 378,879,000 | 408,847,000 | 477,824,000 | 306,982,000 | - | - | - |
| Operating Income (USD) | 243,922,000 | 36,979,000 | (75,046,000) | 273,947,000 | 325,574,000 | 663,422,000 | 378,197,000 | 60,484,000 | 24,438,000 | 28,013,000 | (168,017,000) | - | - | - |
| Operating Margin | 9.3% | 1.5% | (3.0%) | 11.0% | 12.5% | 20.8% | 14.9% | 2.3% | 0.9% | 0.9% | (5.3%) | - | - | - |
| % EBITDA Margin | 13.8% | 6.8% | 3.1% | 18.7% | 21.4% | 29.1% | 26.0% | 14.1% | 14.8% | 15.5% | 9.8% | - | - | - |
| NET Income (USD) | 231,067,000 | 5,003,000 | (69,401,000) | 262,495,000 | 282,392,000 | 483,441,000 | 235,205,000 | 124,657,000 | (41,062,000) | 329,178,000 | 1,043,518,000 | - | - | - |
| % Net Margin | 8.8% | 0.2% | (2.8%) | 10.5% | 10.9% | 15.2% | 9.3% | 4.6% | (1.5%) | 10.7% | 33.2% | - | - | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.